FI822199L - SUBSTITUTE IMIDAZO (1,5-A) PYRIDINER, PHARMACEUTICAL FORM FOR PHARMACEUTICAL FRAMEWORK, PHARMACEUTICAL FORM OF PHARMACEUTICAL FORM, - Google Patents
SUBSTITUTE IMIDAZO (1,5-A) PYRIDINER, PHARMACEUTICAL FORM FOR PHARMACEUTICAL FRAMEWORK, PHARMACEUTICAL FORM OF PHARMACEUTICAL FORM,Info
- Publication number
- FI822199L FI822199L FI822199A FI822199A FI822199L FI 822199 L FI822199 L FI 822199L FI 822199 A FI822199 A FI 822199A FI 822199 A FI822199 A FI 822199A FI 822199 L FI822199 L FI 822199L
- Authority
- FI
- Finland
- Prior art keywords
- pharmaceutical
- pharmaceutical form
- pyridiner
- imidazo
- substitute
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/32—Compounds having groups or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27609481A | 1981-06-22 | 1981-06-22 | |
| US27609481 | 1981-06-22 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI822199A0 FI822199A0 (en) | 1982-06-18 |
| FI822199L true FI822199L (en) | 1982-12-23 |
| FI75569B FI75569B (en) | 1988-03-31 |
| FI75569C FI75569C (en) | 1988-07-11 |
Family
ID=23055137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI822199A FI75569C (en) | 1981-06-22 | 1982-06-18 | ANALOGIFICATION OF FRUIT PROCESSING THERAPEUTIC NETWORK IMIDATION / 1,5-A / PYRIDINER. |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0068386B1 (en) |
| JP (1) | JPS58979A (en) |
| KR (1) | KR890002640B1 (en) |
| AR (1) | AR242032A1 (en) |
| AT (1) | ATE17004T1 (en) |
| AU (1) | AU559666B2 (en) |
| CA (1) | CA1250844A (en) |
| DE (1) | DE3268010D1 (en) |
| DK (1) | DK158227C (en) |
| ES (5) | ES8401069A1 (en) |
| FI (1) | FI75569C (en) |
| GB (1) | GB2101595B (en) |
| GR (1) | GR76844B (en) |
| HU (1) | HU190701B (en) |
| IE (1) | IE53396B1 (en) |
| IL (1) | IL66101A (en) |
| NO (1) | NO159276C (en) |
| NZ (1) | NZ201023A (en) |
| PT (1) | PT75084B (en) |
| ZA (1) | ZA824355B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4444775A (en) * | 1981-06-22 | 1984-04-24 | Ciba-Geigy Corporation | Substituted imidazo[1,5-A]pyridines |
| EP0098690B1 (en) * | 1982-06-14 | 1987-09-09 | Takeda Chemical Industries, Ltd. | Vinyl carboxylic acid derivatives, their production and use |
| US4588732A (en) * | 1982-12-21 | 1986-05-13 | Ciba-Geigy Corporation | Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors |
| US4617307A (en) * | 1984-06-20 | 1986-10-14 | Ciba-Geigy Corporation | Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors |
| US4470986A (en) * | 1982-12-21 | 1984-09-11 | Ciba-Geigy Corporation | Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors |
| ES2036128B1 (en) * | 1991-07-10 | 1993-12-16 | Menarini Lab | PROCEDURE FOR THE PREPARATION OF 4- (IMIDAZO) 1,5-A) PIRIDIN-8L) -1,4-DIHIDROPIRIDINAS. |
| US5468757A (en) * | 1994-01-31 | 1995-11-21 | Eli Lilly And Company | 6-azaindole thromboxane synthase inhibitors |
| EP1565463B1 (en) * | 2002-11-18 | 2008-06-11 | Novartis AG | Imidazo[1,5a] pyridine derivatives and methods for treating aldosterone mediated diseases |
| US7803810B2 (en) | 2007-03-09 | 2010-09-28 | Probiodrug Ag | Inhibitors |
-
1982
- 1982-06-18 FI FI822199A patent/FI75569C/en not_active IP Right Cessation
- 1982-06-18 CA CA000405476A patent/CA1250844A/en not_active Expired
- 1982-06-18 GB GB08217704A patent/GB2101595B/en not_active Expired
- 1982-06-21 ZA ZA824355A patent/ZA824355B/en unknown
- 1982-06-21 IL IL66101A patent/IL66101A/en not_active IP Right Cessation
- 1982-06-21 PT PT75084A patent/PT75084B/en not_active IP Right Cessation
- 1982-06-21 DE DE8282105426T patent/DE3268010D1/en not_active Expired
- 1982-06-21 AT AT82105426T patent/ATE17004T1/en not_active IP Right Cessation
- 1982-06-21 EP EP82105426A patent/EP0068386B1/en not_active Expired
- 1982-06-21 NO NO822062A patent/NO159276C/en unknown
- 1982-06-21 GR GR68489A patent/GR76844B/el unknown
- 1982-06-21 ES ES513307A patent/ES8401069A1/en not_active Expired
- 1982-06-21 AU AU85067/82A patent/AU559666B2/en not_active Ceased
- 1982-06-21 NZ NZ201023A patent/NZ201023A/en unknown
- 1982-06-21 IE IE1458/82A patent/IE53396B1/en not_active IP Right Cessation
- 1982-06-21 DK DK277682A patent/DK158227C/en not_active IP Right Cessation
- 1982-06-21 KR KR8202756A patent/KR890002640B1/en not_active Expired
- 1982-06-21 HU HU822011A patent/HU190701B/en not_active IP Right Cessation
- 1982-06-22 JP JP57106292A patent/JPS58979A/en active Granted
-
1983
- 1983-09-16 ES ES525687A patent/ES8502995A1/en not_active Expired
- 1983-09-16 ES ES525686A patent/ES525686A0/en active Granted
- 1983-09-16 ES ES525688A patent/ES8502996A1/en not_active Expired
- 1983-09-16 ES ES525689A patent/ES8502997A1/en not_active Expired
-
1984
- 1984-01-19 AR AR84295476A patent/AR242032A1/en active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO159724C (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE IMIDAZO (1,2-A) PYRAZINES. | |
| FI810147L (en) | IMIDAZO / 1,2-A / PYRIDINER FOERFANDE FOER FRERSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL COMPOSITION | |
| IT1141960B (en) | PROCEDURE FOR THE PREPARATION OF AROMATIC URETANS | |
| FI820178L (en) | PHARMACEUTICAL FORM OF PHARMACEUTICAL FORM OF FRUIT FRAMEWORK | |
| FI813710A7 (en) | Method for the 5-aroylation of 1,2-dihydro-3H-pyrrolo/1,2-a/pyrrole-1-carboxylic acid esters. | |
| FI832004A7 (en) | Process for the preparation of 1-sulfo-2-oxoazetidine derivatives. | |
| FI820518A7 (en) | Method for the preparation of substituted 3-aminosydnonimines. | |
| FI822187A0 (en) | PHARMACEUTICAL PREPARATION | |
| FI822199A0 (en) | SUBSTITUTE IMIDAZO (1,5-A) PYRIDINER, PHARMACEUTICAL FORM FOR PHARMACEUTICAL FRAMEWORK, PHARMACEUTICAL FORM OF PHARMACEUTICAL FORM, | |
| NO834711L (en) | Imidazo (1,5-A) PYRIDINE-DERIVATIVES | |
| FI822408A7 (en) | Method for the preparation of amidobenzamides. | |
| AR229519A1 (en) | PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 2,3-DIHYDRO-9-PHENYL-1H-PIRAZOLO (1,2-A) -INDAZOLIO | |
| FI821035L (en) | IMIDAZO / 1,2-A / PYRIMIDINDERIVAT, DERAS FRAMSTAELLNING OCH ANVAENDNING VID SJUKVAORD | |
| FI864891A0 (en) | PROCEDURE FOR FRAMSTATION OF 6,7,8,9-TETRAHYDRO-10-METHYLPYRIDO / 1,2-A / INDOL-9-AMINER OCH DERAS DERIVAT. | |
| DK339584A (en) | IMIDAZO (1,5-A) PYRIMIDINE DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF | |
| IT1172120B (en) | PROCEDURE FOR THE PRODUCTION OF CARBOCEMENTATION AGENTS | |
| IT8222353A1 (en) | THIAZOLE (3,2-A) SUBSTITUTED PRIMIDINES AND PROCEDURE FOR THEIR PREPARATION | |
| IT1190920B (en) | BICYCLIC COMPOUNDS AND PROCEDURE FOR THEIR PREPARATION | |
| FI834664A0 (en) | SUBSTITUERADE IMIDAZO (1,5-A) PYRIDINER | |
| ES518499A0 (en) | PROCEDURE FOR THE PREPARATION OF NEW IMIDAZO (1,2-A) PIRIMIDINAS. | |
| RO85277A (en) | PROCESS FOR THE PREPARATION OF ANY IMIDAZOLE PROPIONITRILS | |
| FI842976A7 (en) | Process for the preparation of pharmaceutically active aminopyrimidinone derivatives. | |
| NL193407B (en) | Process for the preparation of 3-exomethylenecepham derivatives. | |
| IT1172155B (en) | PROCEDURE FOR THE PRODUCTION OF CARBOCEMENTATION AGENTS | |
| NL187806C (en) | PROCESS FOR THE CONTINUOUS PREPARATION OF ACID FLUORIDE. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Transfer of assignment of patent |
Owner name: NOVARTIS AG |
|
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: NOVARTIS AG |